BL
XBI icon

BCWM LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BCWM LLC’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-57,663
Closed -$4.78M – 58
2025
Q2 		$4.78M Buy
57,663
+13,291
+30% +$1.06M 1.52% 31
2025
Q1 		$3.6M Buy
44,372
+301
+0.7% +$26.9K 1.25% 34
2024
Q4 		$3.97M Buy
+44,071
New +$4.27M 1.41% 30
2024
Q2 		$3.98M Buy
42,915
+1,742
+4% +$156K 1.43% 33
2024
Q1 		$3.91M Buy
41,173
+25,527
+163% +$2.37M 1.34% 34
2023
Q4 		$1.4M Buy
15,646
+305
+2% +$22.6K 0.47% 50
2023
Q3 		$1.12M Sell
15,341
-37
-0.2% -$2.96K 0.41% 52
2023
Q2 		$1.28M Buy
+15,378
New +$1.29M 0.42% 52
2022
Q4 		– Sell
-32,177
Closed -$2.55M – 61
2022
Q3 		$2.55M Buy
+32,177
New +$2.71M 0.93% 45
2020
Q1 		– Sell
-55,355
Closed -$5.26M – 72
2019
Q4 		$5.26M Buy
55,355
+843
+2% +$72.9K 1.88% 21
2019
Q3 		$4.16M Buy
54,512
+380
+0.7% +$31.6K 1.68% 29
2019
Q2 		$4.75M Buy
54,132
+3,945
+8% +$336K 1.9% 19
2019
Q1 		$4.54M Sell
50,187
-38,811
-44% -$3.3M 2.04% 14
2018
Q4 		$63.9M Buy
88,998
+24,028
+37% +$1.94M 3.04% 4
2018
Q3 		$6.21M Buy
64,970
+536
+0.8% +$52K 2.6% 6
2018
Q2 		$6.13M Sell
64,434
-6,901
-10% -$634K 2.68% 5
2018
Q1 		$6.26M Sell
71,335
-1,878
-3% -$171K 2.66% 5
2017
Q4 		$6.21M Sell
73,213
-765
-1% -$64.1K 2.54% 8
2017
Q3 		$6.4M Buy
73,978
+27
+0% +$2.17K 2.68% 5
2017
Q2 		$5.71M Buy
73,951
+524
+0.7% +$37.2K 2.54% 5
2017
Q1 		$5.09M Sell
73,427
-802
-1% -$53.9K 2.29% 4
2016
Q4 		$4.39M Sell
74,229
-7
-0% -$432 2.04% 12
2016
Q3 		$4.92M Sell
74,236
-837
-1% -$51.8K 2.29% 6
2016
Q2 		$4.06M Buy
+75,073
New +$4.11M 1.95% 15

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BCWM LLC's XBI Position: Q3 2025 in Review

BCWM LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 57,663 shares — an estimated $4.78M sold.

BCWM LLC first reported a position in XBI in Q2 2016 and held it in 24 quarters. The position peaked at $63.9M in Q4 2018. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • BCWM LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
  • BCWM LLC sold 57,663 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $4.78M.
  • BCWM LLC first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 24 quarters.
  • BCWM LLC's State Street SPDR S&P Biotech ETF position peaked at $63.9M in Q4 2018.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on BCWM LLC's 13F filing for Q3 2025, filed 14 Nov 2025.